Gallagher saw its IBD SmartSelect Composite Rating rise to 96 Tuesday, up from 94 the day before.
The new score tells you the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.
Gallagher is trading within a buy range from a 316.72 entry from a cup without handle.
Discover The 3 Keys To Successful Stock Investing
The stock has a 93 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth tops 93% of all stocks.
Its Accumulation/Distribution Rating of C- shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
In Q4, the company posted 17% earnings growth. Top line growth fell to 12%, down from 13% in the previous quarter.
Gallagher holds the No. 4 rank among its peers in the Insurance-Brokers industry group. Ryan Specialty Holdings is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
